In the dynamic and volatile biopharmaceutical marketplace, New Product Planning resources are critical to commercial success.
Yet many companies, including emerging companies with limited commercial staff and larger companies that have downsized their teams, lack the internal expertise or resources to effectively conduct critical activities on their own.
Our experience, expertise and resources can be invaluable in a variety of business scenarios:
Emerging companies with limited or no commercial staff
Need for experience that may not exist within an existing team
Temporary surges in demand for commercialization support
Early stage risk that precludes hiring fixed NPP resources
Long-term or fixed-term solutions for organizations desiring to reduce NPP FTEs
Our team members seamlessly integrate into the NPP function of our clients’ companies. Working in tandem with your senior leadership, Skysis can help develop a fully comprehensive commercialization plan or work with your existing plan to maximize the potential of your future product.
Experiencing an increase in marketing activities due to product launch, annual planning or acute competitive threats? Count on Skysis’ experienced professionals and proven processes to overcome limitations in resources and expertise when you need it most.
Learn more about Skysis’ comprehensive, detailed, and fully integrated commercialization planning framework. This customized deliverable includes cost roll-up across all initiatives, with a revenue forecast to generate financial scenarios (i.e. P&L, NPV, Cash Flow, etc.) from starting point to 5 years post launch.
From early development and pivotal clinical trials to launch and lifecycle management, Skysis MA professionals have the insight and expertise to navigate the changing healthcare landscape and understand the most influential levers that impact product access.
Introducing “Two Thumbs Up,” a comprehensive offering from Skysis that enables biopharmaceutical professionals to confidently make the go/no-go decision relative to a drug’s commercial potential, regulatory pathway, and clinical development feasibility.
We measure value based on our ability to integrate competitive insights into a client’s brand planning and corporate strategy development. Skysis Competitive Intelligence professionals have earned advanced degrees and average twenty years’ experience in the pharmaceutical industry and/or medical field. Customize your team, choosing from MDs with clinical research experience, PhDs with clinical and commercial industry experience, and PharmDs & MBAs with significant competitive intelligence experience.